MedicalResearch.com Interview with:
Robert Wong, MD, MS, FACG
Assistant Clinical Professor of Medicine
Director, GI Education & Research
Highland Hospital I A member of Alameda Health System
Oakland, CA 94602
MedicalResearch.com: What is the background for this study?
Response: Alcoholic liver disease is a major cause of chronic liver disease in the United States and has become the leading indication for liver transplantation in the U.S. However, accurate estimates of the true burden among U.S. adults is not well studies due to challenges in accurately identifying alcoholic liver disease or lack of awareness is screening individuals for alcohol use disorder. Given the gaps in knowledge regarding the epidemiology of alcoholic liver disease in the U.S., our current study attempts to further contribute to the understanding of alcoholic liver disease epidemiology in the U.S
We utilized a U.S. national cross sectional database and focused on the specific subset of alcoholic fatty liver disease, which is the earlier stage of disease along the spectrum of alcoholic liver disease. Focusing on alcoholic fatty liver disease allowed us to more accurately define and capture the prevalence of this disease. Furthermore, given that alcoholic fatty liver disease is early on the overall spectrum of alcoholic liver disease, it is a disease state that early identification provides opportunities to implement therapy and counseling for alcohol abstinence that can prevent further liver damage and disease progression.